Latest Period
Q1 2026
Security Snapshot
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) Institutional Ownership
CUSIP: 89455T109
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
115
Shares (Excl. Options)
35,922,342
Price
$1.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $0.001 par value
- Symbol
- TMCI on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 35,922,342
- Total 13F value
- $48,144,954
- Portfolio coverage rank
- 0%
- Share change
- +2,282,925
- Value change
- -$3,585,475
- Number of holders
- 115
- Shares outstanding
- 64,609,137
- SEC-reported price per share
- $3.08
- Insider filing price
- $3.08
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value is tracked under CUSIP 89455T109.
- 115 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 114 to 115 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $87,953,121 to $48,144,954.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 115 institutions filings for Q1 2026.
Security key
89455T109
Latest holder period
Q1 2026
13F holders
115
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
TMCI full holder history
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
TREACE MEDICAL CONCEPTS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 89455T109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
TMCI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.8% | -1.4% | $12,791,640 | 6,364,000 | 0% | Armistice Capital, LLC | 31 Mar 2026 | |
| GAGNON SECURITIES LLC | 9.6% | +55% | $15,355,268 | +$5,406,632 | 6,142,107 | +54% | Neil Gagnon | 31 Dec 2025 |
| BANK OF AMERICA CORP /DE/ | 5.5% | $7,102,886 | 3,533,774 | BANK OF AMERICA CORP /DE/ | 31 Mar 2026 | |||
| MORGAN STANLEY | 3.4% | $13,931,448 | 2,091,809 | Morgan Stanley | 31 Dec 2024 | |||
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.8% | -67% | $2,863,745 | -$6,297,435 | 1,145,498 | -69% | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 115 institutional investors reported holding 35,922,342 shares of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI). This represents 56% of the company’s total 64,609,137 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
51%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | 6,364,000 | 0% | 0.28% | $8,527,760 |
| GAGNON SECURITIES LLC | 8.1% | 5,201,886 | +67% | 1.6% | $6,970,527 |
| BlackRock, Inc. | 5.2% | 3,340,023 | -2.1% | 0% | $4,475,632 |
| BANK OF AMERICA CORP /DE/ | 5% | 3,214,293 | +39% | 0% | $4,307,153 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3% | 1,461,507 | 0% | 0% | $1,958,419 |
| STATE STREET CORP | 1.9% | 1,235,518 | +24% | 0% | $1,655,594 |
| CIBC Bancorp USA Inc. | 1.9% | 1,218,353 | 0% | $1,632,593 | |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 1,148,115 | -24% | 0% | $1,538,474 |
| AQR CAPITAL MANAGEMENT LLC | 1.6% | 1,061,840 | 0% | $1,422,866 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,010,843 | -12% | 0% | $1,354,788 |
| ACADIAN ASSET MANAGEMENT LLC | 1.5% | 941,293 | +42% | 0% | $1,255,000 |
| D. E. Shaw & Co., Inc. | 1.3% | 841,269 | +34% | 0% | $1,127,300 |
| CITADEL ADVISORS LLC | 1.3% | 825,575 | +290% | 0% | $1,106,270 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 0.91% | 589,617 | 0% | 0.79% | $790,087 |
| UBS Group AG | 0.84% | 542,905 | +85% | 0% | $727,493 |
| RENAISSANCE TECHNOLOGIES LLC | 0.81% | 522,900 | 0% | $700,686 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.67% | 435,893 | 0% | 0% | $584,097 |
| NORTHERN TRUST CORP | 0.63% | 405,903 | +3.1% | 0% | $543,910 |
| GSA CAPITAL PARTNERS LLP | 0.62% | 398,007 | +14% | 0.03% | $533,000 |
| GOLDMAN SACHS GROUP INC | 0.6% | 387,685 | +105% | 0% | $519,498 |
| RAYMOND JAMES FINANCIAL INC | 0.55% | 357,556 | +11% | 0% | $479,125 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.51% | 328,839 | -6.7% | 0% | $440,644 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 318,004 | 0% | 0% | $426,125 |
| XTX Topco Ltd | 0.44% | 285,780 | +289% | 0.01% | $382,945 |
| MARSHALL WACE, LLP | 0.41% | 264,933 | 0% | $355,010 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 35,922,342 | $48,144,954 | -$3,585,475 | $1.34 | 115 |
| 2025 Q4 | 35,847,129 | $87,953,121 | -$21,913,008 | $2.45 | 114 |
| 2025 Q3 | 38,823,239 | $260,292,697 | +$3,224,800 | $6.71 | 117 |
| 2025 Q2 | 38,411,285 | $225,932,843 | +$594,572 | $5.88 | 122 |
| 2025 Q1 | 37,892,233 | $314,933,438 | +$6,396,329 | $8.39 | 136 |
| 2024 Q4 | 37,307,543 | $277,767,394 | -$15,594,697 | $7.44 | 133 |
| 2024 Q3 | 39,629,299 | $229,799,434 | +$2,450,302 | $5.80 | 133 |
| 2024 Q2 | 39,705,068 | $264,072,594 | -$75,189,680 | $6.65 | 126 |
| 2024 Q1 | 41,245,049 | $537,228,351 | +$3,488,774 | $13.05 | 129 |
| 2023 Q4 | 41,010,068 | $522,886,552 | +$21,281,231 | $12.75 | 126 |
| 2023 Q3 | 39,193,648 | $513,809,790 | -$36,596,248 | $13.11 | 121 |
| 2023 Q2 | 38,926,750 | $995,556,262 | +$84,284,218 | $25.58 | 135 |
| 2023 Q1 | 35,535,142 | $895,139,591 | +$184,017,260 | $25.19 | 122 |
| 2022 Q4 | 26,874,663 | $617,852,430 | +$44,023,715 | $22.99 | 105 |
| 2022 Q3 | 26,104,333 | $576,118,458 | +$73,324,010 | $22.07 | 90 |
| 2022 Q2 | 23,108,213 | $331,376,313 | +$38,889,452 | $14.34 | 81 |
| 2022 Q1 | 20,370,513 | $385,285,843 | +$38,473,149 | $18.91 | 74 |
| 2021 Q4 | 17,228,093 | $320,930,460 | +$66,992,636 | $18.64 | 74 |
| 2021 Q3 | 13,036,758 | $350,676,095 | -$6,970,436 | $26.90 | 61 |
| 2021 Q2 | 13,009,799 | $406,683,468 | +$406,677,512 | $31.26 | 70 |
| 2021 Q1 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q4 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q3 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q2 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q1 | 179 | $6,000 | $33.52 | 1 |